Cysteine dioxygenase

Last updated
Cysteine dioxygenase
CDO full structure.png
Human CDO (drawn from PDB 2IC1)
Identifiers
EC no. 1.13.11.20
CAS no. 37256-59-0
Databases
IntEnz IntEnz view
BRENDA BRENDA entry
ExPASy NiceZyme view
KEGG KEGG entry
MetaCyc metabolic pathway
PRIAM profile
PDB structures RCSB PDB PDBe PDBsum
Search
PMC articles
PubMed articles
NCBI proteins
cysteine dioxygenase, type I
6cdn.jpg
Cysteine dioxygenase 1, monomer, Human
Identifiers
SymbolCDO1
NCBI gene 1036
HGNC 1795
OMIM 603943
RefSeq NM_001801
UniProt Q16878
Other data
EC number 1.13.11.20
Locus Chr. 5 q23.2
Search for
Structures Swiss-model
Domains InterPro

Cysteine dioxygenase (CDO) is a non-heme iron enzyme that catalyzes the conversion of L-cysteine to cysteine sulfinic acid (cysteine sulfinate). CDO plays an important role in cysteine catabolism, regulating intracellular levels of cysteine and responding changes in cysteine availability. [1] As such, CDO is highly regulated and undergoes large changes in concentration and efficiency. It oxidizes cysteine to the corresponding sulfinic acid by activation of dioxygen, although the exact mechanism of the reaction is still unclear. In addition to being found in mammals, CDO also exists in some yeast and bacteria, although the exact function is still unknown. [2] [3] CDO has been implicated in various neurodegenerative diseases and cancers, which is likely related to cysteine toxicity. [1] [2]

Contents

Function

CDO is responsible for the first major step in metabolism of cysteine. [4] CDO oxidizes to cysteine sulfinic acid (which exists predominantly in the anionic sulfinate form in vivo). Overall, CDO catalyzes the addition of dioxygen (O2) [5] to a thiol, producing a sulfinic acid. More specifically, CDO is part of the group of non-heme iron oxygenases that employ oxygen as an electron acceptor. Cysteine sulfinic acid is then metabolized further via two divergent pathways: decarboxylated to hypotaurine by sulfinoalanine decarboxylase and oxidized to taurine by hypotaurine dehydrogenase; or transaminated to a putative 3-sulfinylpyruvate intermediate, which decomposes spontaneously into pyruvate and sulfite. [1] [6] Sulfite can then be oxidized to sulfate by sulfite oxidase. [1] Thus CDO is necessary for hypotaurine/taurine and sulfite/sulfate production. The role of CDO may vary between cell types as it can either be used primarily for taurine or sulfate production or for degradation of cysteine. [1]

CDO reaction scheme showing cysteine sulfinic acid formation from cysteine by dioxygen incorporation Cysteine dioxygenase reaction.svg
CDO reaction scheme showing cysteine sulfinic acid formation from cysteine by dioxygen incorporation

Structure

Active site of CDO, with iron (II) bound to cysteine substrate and key residues highlighted. Generated from 2IC1. CDO active site.png
Active site of CDO, with iron (II) bound to cysteine substrate and key residues highlighted. Generated from 2IC1.

CDO is a 22.5 kDa protein [2] that contains 200 amino acid residues [3] and has an isoelectric point (pI) of 5.5. [2] The primary structure is highly conserved between mammalian species, with murine and human CDO differing in only 16 residues. [3] CDO is part of the cupin superfamily, [2] whose members possess a 6-stranded β-barrel [8] in a "jelly-roll" topology. [3] Crystal structures of the protein have been obtained at 1.5 Å resolution (mouse). [1] The active site displays a unique geometry where instead of the typical facial triad of two histidines and one carboxylate side-chain coordinating to an iron (II) species, [9] three histidine ligands are bound to iron. [2] [3] [8] Furthermore, crystal structures show the amino nitrogen and thiolate sulfur of cysteine coordinated to the iron in addition to a single water molecule (see figure). [2]

CDO contains a unique internal cofactor created by intramolecular thioether formation between Cys93 and Tyr157, which is postulated to participate in catalysis. [1] When the protein was first isolated, two bands on agarose gel were observed, [3] corresponding to the cofactor-containing protein and the unlinked "immature" protein, respectively. Crosslinking increases efficiency of CDO ten-fold and is regulated by levels of cysteine, an unusual example of protein cofactor formation mediated by substrate (feedforward activation). [1]

Mechanism

The CDO mechanism is still not well understood, despite active research to elucidate details of the reaction. [2] Overall, the reaction involves addition of O2 to cysteine, which occurs spontaneously without enzyme catalysis. [3] Studies have shown that the cysteinyltyrosine bridge lowers the oxidation potential of tyrosine (commonly an electron donor, as in photosystem II) by ~0.5 V relative to phenol and increases its acidity. [2] The thioether moiety likely plays a structural, redox, or, acid/base role. Other studies have shown that Tyr157 is needed for enzyme function (possibly as a tyrosinyl radical) and is highly conserved across CDO variants. [2] Furthermore, research has shown that cysteamine, a structurally similar molecule to cysteine, enhances cysteine oxidation but is not a substrate. [2] [6]

Proposed mechanism of CDO Cysteine dioxyenase mechanism.png
Proposed mechanism of CDO

One proposed mechanism, supported by computational and spectroscopic studies, involves O2 binding cis to a thiolate to form reactive iron (III)-superoxo species (A), which then attacks the bound sulfur of cysteine to form a four-membered ring structure (B). [10] [11] [12] Heterolytic O-O bond cleavage then affords a high-valent iron (IV) oxo intermediate (C), which transfers the second oxygen to sulfur. [10] [11]

Regulation

CDO is tightly regulated in the cell to maintain cysteine homeostasis. In particular, CDO responds to changes in dietary cysteine availability and protein intake, maintaining decreased activity with low cysteine levels and increased activity at high levels to prevent cytotoxicity. [1] Studies have shown that CDO can exhibit a dramatic increase in hepatic activity within hours. Unlike many enzymes, it is predominantly regulated at the level of protein turnover rather than transcriptional (mRNA levels). High cysteine levels inhibit ubiquitinylation, which lowers the rate of proteasomal degradation. [1] CDO is also regulated in adipose tissue, where high cysteine levels cause increased hypotaurine/taurine production. [1] Regulation of CDO is also thought to involve both the crosslinked and immature forms of the protein.

Disease Relevance

Because of its relevance to cysteine metabolism, changes in CDO activity may cause disease in humans. Research has found that elevated cysteine can by cytotoxic, neurotoxic, [1] and excitotoxic. [2] Abnormal or deficient CDO activity has been linked to Alzheimer's disease, Parkinson's disease, rheumatoid arthritis, [13] and motor neuron diseases. [1] [2] [14] In these diseases, patients display depressed sulfate levels, elevated fasting cysteine plasma concentrations, and other symptoms consistent with impaired cysteine oxidation. [1] CDO deficiency and subsequent cysteine accumulation in the globus pallidus has been linked to Pantothenate kinase-associated neurodegeneration. [15]

The expression of CDO is altered in cancer cells [2] and methylation of the CDO1 (human cysteine dioxygenase type I) promoter gene was shown to occur in colon, breast, esophageal, lung, bladder, and stomach cancers. [16] Silencing of CDO1 is a critical epigenetic event in breast cancer, leading to downregulation of CDO1 activity. [16] [17] In particular, decreased CDO1 activity causes increased hydrogen sulfide (H2S), which has been connected to various diseases. [16] These results suggest that CDO1 (human cysteine dioxygenase type I) acts as a tumor suppressor gene and may potentially serve as a biomarker for cancer. [16]

Related Research Articles

<span class="mw-page-title-main">Sulfur</span> Chemical element, symbol S and atomic number 16

Sulfur (also spelled sulphur in British English) is a chemical element; it has symbol S and atomic number 16. It is abundant, multivalent and nonmetallic. Under normal conditions, sulfur atoms form cyclic octatomic molecules with the chemical formula S8. Elemental sulfur is a bright yellow, crystalline solid at room temperature.

<span class="mw-page-title-main">Cysteine</span> Proteinogenic amino acid

Cysteine is a semiessential proteinogenic amino acid with the formula HOOC−CH(−NH2)−CH2−SH. The thiol side chain in cysteine often participates in enzymatic reactions as a nucleophile. Cysteine is chiral, but interestingly, both D and L-cysteine are found in nature with D-cysteine having been found in developing brain. Cysteine is named after its discovery in urine, which comes from the urinary bladder or cyst, from kystis "bladder".

<span class="mw-page-title-main">Methionine</span> Sulfur-containing amino acid

Methionine is an essential amino acid in humans.

<span class="mw-page-title-main">Taurine</span> Aminosulfonic acid not incorporated into proteins

Taurine, or 2-aminoethanesulfonic acid, is a non-proteinogenic amino sulfonic acid that is widely distributed in animal tissues. It is a major constituent of bile and can be found in the large intestine, and accounts for up to 0.1% of total human body weight.

Sulfonucleotide reductases are a class of enzymes involved in reductive sulfur assimilation. This reaction consists of a conversion from activated sulfate to sulfite.. The sulfite is used in essential biomolecules such as cysteine. The sulfonucleotide reductases are through to have all evolved from a common ancestor.

Cysteine metabolism refers to the biological pathways that consume or create cysteine. The pathways of different amino acids and other metabolites interweave and overlap to creating complex systems.

<span class="mw-page-title-main">Sulfite oxidase</span>

Sulfite oxidase is an enzyme in the mitochondria of all eukaryotes, with exception of the yeasts. It oxidizes sulfite to sulfate and, via cytochrome c, transfers the electrons produced to the electron transport chain, allowing generation of ATP in oxidative phosphorylation. This is the last step in the metabolism of sulfur-containing compounds and the sulfate is excreted.

<span class="mw-page-title-main">Methyltransferase</span> Group of methylating enzymes

Methyltransferases are a large group of enzymes that all methylate their substrates but can be split into several subclasses based on their structural features. The most common class of methyltransferases is class I, all of which contain a Rossmann fold for binding S-Adenosyl methionine (SAM). Class II methyltransferases contain a SET domain, which are exemplified by SET domain histone methyltransferases, and class III methyltransferases, which are membrane associated. Methyltransferases can also be grouped as different types utilizing different substrates in methyl transfer reactions. These types include protein methyltransferases, DNA/RNA methyltransferases, natural product methyltransferases, and non-SAM dependent methyltransferases. SAM is the classical methyl donor for methyltransferases, however, examples of other methyl donors are seen in nature. The general mechanism for methyl transfer is a SN2-like nucleophilic attack where the methionine sulfur serves as the leaving group and the methyl group attached to it acts as the electrophile that transfers the methyl group to the enzyme substrate. SAM is converted to S-Adenosyl homocysteine (SAH) during this process. The breaking of the SAM-methyl bond and the formation of the substrate-methyl bond happen nearly simultaneously. These enzymatic reactions are found in many pathways and are implicated in genetic diseases, cancer, and metabolic diseases. Another type of methyl transfer is the radical S-Adenosyl methionine (SAM) which is the methylation of unactivated carbon atoms in primary metabolites, proteins, lipids, and RNA.

<span class="mw-page-title-main">Sulfinic acid</span> Class of chemical compounds

Sulfinic acids are oxoacids of sulfur with the structure RSO(OH). In these organosulfur compounds, sulfur is pyramidal.

<span class="mw-page-title-main">Cystathionine beta synthase</span> Mammalian protein found in humans

Cystathionine-β-synthase, also known as CBS, is an enzyme (EC 4.2.1.22) that in humans is encoded by the CBS gene. It catalyzes the first step of the transsulfuration pathway, from homocysteine to cystathionine:

<span class="mw-page-title-main">Cystathionine</span> Chemical compound

Cystathionine is an intermediate in the synthesis of cysteine from homocysteine. It is produced by the transsulfuration pathway and is converted into cysteine by cystathionine gamma-lyase (CTH).

In enzymology, a taurine dioxygenase (EC 1.14.11.17) is an enzyme that catalyzes the chemical reaction.

In enzymology, a cysteamine dioxygenase (EC 1.13.11.19) is an enzyme that catalyzes the chemical reaction

<span class="mw-page-title-main">Dioxygenase</span> Class of enzymes

Dioxygenases are oxidoreductase enzymes. Aerobic life, from simple single-celled bacteria species to complex eukaryotic organisms, has evolved to depend on the oxidizing power of dioxygen in various metabolic pathways. From energetic adenosine triphosphate (ATP) generation to xenobiotic degradation, the use of dioxygen as a biological oxidant is widespread and varied in the exact mechanism of its use. Enzymes employ many different schemes to use dioxygen, and this largely depends on the substrate and reaction at hand.

<span class="mw-page-title-main">Cysteine sulfinic acid</span> Chemical compound

Cysteine sulfinic acid is the organic compound with the nominal formula HO2SCH2CH(NH2)CO2H. It is a rare example of an amino acid bearing a sulfinic acid functional group. It is a white solid that is soluble in water. Like most natural amino acids, it is chiral, only the d-enantiomer occurs in nature, and it exists as the zwitterion at neutral pH. It is an intermediate in cysteine metabolism. It is not a coded amino acid, but is produced post-translationally. Peptides containing the cysteine sulfinic acid residue are substrates for cysteine sulfinic acid reductase.

<span class="mw-page-title-main">Hypotaurine</span> Chemical compound

Hypotaurine is a sulfinic acid that is an intermediate in the biosynthesis of taurine. Like taurine, it also acts as an endogenous neurotransmitter via action on the glycine receptors. It is an osmolyte with antioxidant properties.

<span class="mw-page-title-main">TauD protein domain</span>

In molecular biology, TauD refers to a protein domain that in many enteric bacteria is used to break down taurine as a source of sulfur under stress conditions. In essence, they are domains found in enzymes that provide bacteria with an important nutrient.

<span class="mw-page-title-main">Transition metal thiolate complex</span>

Transition metal thiolate complexes are metal complexes containing thiolate ligands. Thiolates are ligands that can be classified as soft Lewis bases. Therefore, thiolate ligands coordinate most strongly to metals that behave as soft Lewis acids as opposed to those that behave as hard Lewis acids. Most complexes contain other ligands in addition to thiolate, but many homoleptic complexes are known with only thiolate ligands. The amino acid cysteine has a thiol functional group, consequently many cofactors in proteins and enzymes feature cysteinate-metal cofactors.

<span class="mw-page-title-main">GADL1</span> Enzyme

Glutamate decarboxylase like 1 (GADL1) is the enzyme responsible for decarboxylating aspartate (Asp) to β-alanine and cysteine sulfinic acid (CSA) to hypotaurine. GADL1 is a Pyridoxal 5’-phosphate (PLP)-dependent enzyme. By decarboxylating Asp to β-alanine, GADL1 consequently plays a role in the production of carnosine. Carnosine and taurine have multiple biological functions such as calcium regulation, pH buffering, metal chelation, and antioxidant effects. β-Alanine also plays a role as neurotransmitter or neuromodulator in the central nervous system (CNS) and olfactory bulbs.

<span class="mw-page-title-main">Isethionate sulfite-lyase</span> Bacterial Enzyme

Isethionate sulfite-lyase is a glycyl radical enzyme that catalyzes the degradation of isethionate into acetaldehyde and sulfite through the cleavage of a carbon-sulfur bond. This conversion is a necessary step for taurine catabolism in anaerobic bacteria like Bilophila wadsworthia. IslA is activated by the enzyme IslB which uses S-adenoslymethionine (SAM) as the initial radical donor.

References

  1. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Stipanuk MH, Ueki I, Dominy JE, Simmons CR, Hirschberger LL (May 2009). "Cysteine dioxygenase: a robust system for regulation of cellular cysteine levels". Amino Acids. 37 (1): 55–63. doi:10.1007/s00726-008-0202-y. PMC   2736881 . PMID   19011731.
  2. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Joseph CA, Maroney MJ (August 2007). "Cysteine dioxygenase: structure and mechanism". Chemical Communications (32): 3338–49. doi:10.1039/B702158E. PMID   18019494.
  3. 1 2 3 4 5 6 7 Stipanuk MH, Simmons CR, Karplus PA, Dominy JE (June 2011). "Thiol dioxygenases: unique families of cupin proteins". Amino Acids. 41 (1): 91–102. doi:10.1007/s00726-010-0518-2. PMC   3136866 . PMID   20195658.
  4. Chai SC, Jerkins AA, Banik JJ, Shalev I, Pinkham JL, Uden PC, et al. (March 2005). "Heterologous expression, purification, and characterization of recombinant rat cysteine dioxygenase". The Journal of Biological Chemistry. 280 (11): 9865–9. doi: 10.1074/jbc.M413733200 . PMID   15623508.
  5. Lombardini JB, Singer TP, Boyer PD (March 1969). "Cystein oxygenase. II. Studies on the mechanism of the reaction with 18oxygen". The Journal of Biological Chemistry. 244 (5): 1172–5. doi: 10.1016/S0021-9258(18)91825-9 . PMID   5767301.
  6. 1 2 Sakakibara S, Yamaguchi K, Hosokawa Y, Kohashi N, Ueda I (February 1976). "Purification and some properties of rat liver cysteine oxidase (cysteine dioxygenase)". Biochimica et Biophysica Acta (BBA) - Enzymology. 422 (2): 273–9. doi:10.1016/0005-2744(76)90138-8. PMID   2307.
  7. Ye S, Wu X, Wei L, Tang D, Sun P, Bartlam M, et al. (February 2007). "An insight into the mechanism of human cysteine dioxygenase. Key roles of the thioether-bonded tyrosine-cysteine cofactor". The Journal of Biological Chemistry. 282 (5): 3391–402. doi: 10.1074/jbc.M609337200 . PMID   17135237.
  8. 1 2 McCoy JG, Bailey LJ, Bitto E, Bingman CA, Aceti DJ, Fox BG, et al. (February 2006). "Structure and mechanism of mouse cysteine dioxygenase". Proceedings of the National Academy of Sciences of the United States of America. 103 (9): 3084–9. Bibcode:2006PNAS..103.3084M. doi: 10.1073/pnas.0509262103 . PMC   1413891 . PMID   16492780.
  9. Gardner JD, Pierce BS, Fox BG, Brunold TC (July 2010). "Spectroscopic and computational characterization of substrate-bound mouse cysteine dioxygenase: nature of the ferrous and ferric cysteine adducts and mechanistic implications". Biochemistry. 49 (29): 6033–41. doi:10.1021/bi100189h. PMC   2914100 . PMID   20397631.
  10. 1 2 3 Tchesnokov EP, Faponle AS, Davies CG, Quesne MG, Turner R, Fellner M, et al. (July 2016). "An iron-oxygen intermediate formed during the catalytic cycle of cysteine dioxygenase". Chemical Communications. 52 (57): 8814–7. doi:10.1039/C6CC03904A. PMC   5043143 . PMID   27297454.
  11. 1 2 3 Villar-Acevedo G, Lugo-Mas P, Blakely MN, Rees JA, Ganas AS, Hanada EM, et al. (January 2017). "Metal-Assisted Oxo Atom Addition to an Fe(III) Thiolate". Journal of the American Chemical Society. 139 (1): 119–129. doi:10.1021/jacs.6b03512. PMC   5262503 . PMID   28033001.
  12. Kumar D, Thiel W, de Visser SP (March 2011). "Theoretical study on the mechanism of the oxygen activation process in cysteine dioxygenase enzymes". Journal of the American Chemical Society. 133 (11): 3869–82. doi:10.1021/ja107514f. PMID   21344861.
  13. Emery P, Bradley H, Arthur V, Tunn E, Waring R (July 1992). "Genetic factors influencing the outcome of early arthritis--the role of sulphoxidation status". British Journal of Rheumatology. 31 (7): 449–51. doi:10.1093/rheumatology/31.7.449. PMID   1628166.
  14. Heafield MT, Fearn S, Steventon GB, Waring RH, Williams AC, Sturman SG (March 1990). "Plasma cysteine and sulphate levels in patients with motor neurone, Parkinson's and Alzheimer's disease". Neuroscience Letters. 110 (1–2): 216–20. doi:10.1016/0304-3940(90)90814-p. PMID   2325885. S2CID   26672064.
  15. Stipanuk MH, Dominy JE, Lee JI, Coloso RM (June 2006). "Mammalian cysteine metabolism: new insights into regulation of cysteine metabolism". The Journal of Nutrition. 136 (6 Supplement): 1652S–1659S. doi: 10.1093/jn/136.6.1652S . PMID   16702335.
  16. 1 2 3 4 Brait M, Ling S, Nagpal JK, Chang X, Park HL, Lee J, et al. (September 2012). "Cysteine dioxygenase 1 is a tumor suppressor gene silenced by promoter methylation in multiple human cancers". PLOS ONE. 7 (9): e44951. Bibcode:2012PLoSO...744951B. doi: 10.1371/journal.pone.0044951 . PMC   3459978 . PMID   23028699.
  17. Jeschke J, O'Hagan HM, Zhang W, Vatapalli R, Calmon MF, Danilova L, et al. (June 2013). "Frequent inactivation of cysteine dioxygenase type 1 contributes to survival of breast cancer cells and resistance to anthracyclines". Clinical Cancer Research. 19 (12): 3201–11. doi:10.1158/1078-0432.CCR-12-3751. PMC   3985391 . PMID   23630167.